Orgenesis Inc. (ORGS) Net earnings per share (EPS TTM)

ORGS (Orgenesis Corp) - company brandmark

The rolling net income per share trend for Orgenesis Inc. (ORGS) on GURU.Markets reflects market expectations, with the current mark at -8.51. Orgenesis Inc. (ORGS) generates revenue through CDMO services and the implementation of manufacturing platforms. Growth is driven by the deployment of mobile laboratories within clinics to reduce therapy costs. Business development relies on the active establishment of joint bio-centers with regional hospitals without merging capital.

ORGS Orgenesis Corporation Earnings per share for the last 12 months (07/04/2022 - 10/26/2024)

Metric breakdowns and analytics for Orgenesis Inc (ORGS)

- stock price and consensus target price:
Stock Price Orgenesis Inc.|ORGS - Analyst Target Range
- market capitalization details:
Market Capitalization Orgenesis Inc.|ORGS - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Orgenesis|ORGS - Accounting Capitalization|Market Capitalization to Book Value Ratio orgenesis.com|ORGS - Company Assets
- debt and liquidity details:
Debt to Equity Orgenesis Inc.|ORGS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Orgenesis Corp|ORGS - Company Total Debt Obligations|Debt to Book Capitalization Ratio Orgenesis Inc.|ORGS - Long-Term Debt Volume|Company Current Liabilities Orgenesis|Quick Ratio orgenesis.com
- earnings and multiples data:
ORGS - Net Financial Result|Expected Profit Orgenesis Inc.|ORGS - Price to Earnings Multiple|Forward P/E Multiple Orgenesis|ORGS - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Orgenesis Inc.|ORGS - Operating income before deduction of amortization|Earnings per share for the last twelve months Orgenesis|ORGS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months orgenesis.com|ORGS - Earnings per share increase in current year|Earnings growth forecast for next year Orgenesis Inc.
Fundamental company analysis:ORGS - Orgenesis Inc.
Mass-produced product of Orgenesis Inc

Selecting assets with a high margin of safety begins with an analysis of the business's real yield. This indicator measures net profit distributed per share annually, eliminating market noise and capturing actual solvency. For Orgenesis Inc. (ORGS), this confirms the effective monetization of cloud IT platforms and cellular manufacturing. Profit stability reflects the b2b ecosystem's resilience to vendor turnover. The trend of the rolling annual earnings per share clearly demonstrates the balance between operational resilience and growth investments.

Competitors of Orgenesis Inc.

Veeva Systems Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year doximity.com (DOCS)|HQY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Waystar Health (WAY)|Earnings per share for the last twelve months CorVel Healthcare|Earnings per share for the last 12 months PRVA (Privia Medical Group)|Net earnings per share (EPS TTM) HURN|CERT - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Omnicell OMCL|Net earnings per share for the last four quarters GoodRx Inc (GDRX)|Schrödinger Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Phreesia Health PHR|Omada Health Inc (OMDA) - Earnings per share for the last twelve months|EVH - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HSTM|DH: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CCSI|Net earnings per share for the last four quarters Agilon Health Corp|Earnings per share for the last twelve months Absci ABSI|SY: Earnings per share for the last 12 months|NRC Health - Net earnings per share (EPS TTM)|Spok Holdings Inc (SPOK) - Net earnings per share for the last 12 months|OPRX (OptimizeRx Corp.) - Net earnings per share for the last 12 months|TBRG - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Simulations Plus, Inc.|Net earnings per one share for the last twelve months SOPHiA GENETICS S.A. SOPH|Earnings per share for the last twelve months Health Catalyst (HCAT)|CCLD (carecloud.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RSSS (Research Solutions)|Net earnings per share for the trailing year DLH Corp|ONMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters scienture.com SCNX|HCTI: Net earnings per share (EPS TTM)|ISPC - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months BFRG|WORX (SCWorx Inc) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months MSPR (MSP Recovery Inc)|ICCT (icoreconnect.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months TRxADE HEALTH MEDS|RCM - Net earnings per share for the last 12 months|Sharecare, Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Streamline Health, Inc.|SYRA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months AMEH|Earnings per share for the last twelve months Model N|Net earnings per one share for the last twelve months NextGen Healthcare Inc NXGN